Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells
Treatment of Patients With Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells
Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
A PHASE1/PHASE2 clinical study on Allergic Rhinitis and Rhinosinusitis Chronic, this trial is ongoing. The trial is conducted by Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1/PHASE2
Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Feb 2024 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
Status: Not Yet Recruiting → Unknown Status
-
Feb 2022 — Feb 2024 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jan 2022 — Feb 2022 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
- The Republican Center for Research and Practice in Otolaryngology
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.